Valuation: General Biologicals Corporation

Market Cap 797M 24.76M 21.72M 20.12M 18.51M 35.01M 2.37B 35.69M 240M 94.03M 1.16B 92.98M 90.95M 4.02B P/E 2024
-5.68x
P/E 2025 1.73x
Enterprise Value 2.66B 82.61M 72.46M 67.11M 61.75M 117M 7.91B 119M 800M 314M 3.88B 310M 303M 13.41B EV / Sales 2024
13.2x
EV / Sales 2025 12.3x
Free-Float
84.47%
Yield 2024 *
-
Yield 2025 -
1 day+7.14%
1 week+9.22%
Current month-2.17%
1 month-5.86%
3 months+171.08%
6 months-10.00%
Current year-12.45%
1 week 10
Extreme 10
12.6
1 month 9.74
Extreme 9.74
15.2
Current year 3.5
Extreme 3.5
15.2
1 year 3.5
Extreme 3.5
18
3 years 3.5
Extreme 3.5
30.2
5 years 3.5
Extreme 3.5
55.3
10 years 3.5
Extreme 3.5
278
Manager TitleAgeSince
Chief Executive Officer - 2018-06-28
Director of Finance/CFO - 2023-12-25
Corporate Officer/Principal - 2013-06-17
Director TitleAgeSince
Chairman - 1989-05-24
Director/Board Member - 2013-07-14
Director/Board Member - 2013-07-14
Change 5-day change 1-year change 3-year change Capi.($)
+7.14%+9.22%-29.69%-52.03% 24.76M
-1.03%-6.17%+215.22%+307.83% 21B
+1.50%+1.87%-40.61%-24.56% 9.53B
-0.24%+2.50%+29.62%+24.84% 6.86B
-2.25%+4.42%+226.33%-27.51% 5.3B
+1.47%+7.93%-19.88%-29.81% 5.12B
+0.41%-4.21%-35.65% - 4.82B
0.00%-0.97%-23.35%-26.37% 4.2B
-5.85%-12.54%+51.09%+59.58% 3.42B
+1.36%+0.22%-17.57%-44.14% 2.63B
Average +0.25%+1.37%+35.55%+20.87% 6.29B
Weighted average by Cap. -0.44%-0.83%+84.13%+104.64%

Financials

2024 2025
Net sales 252M 7.83M 6.87M 6.36M 5.85M 11.07M 749M 11.28M 75.8M 29.73M 368M 29.4M 28.76M 1.27B 216M 6.7M 5.88M 5.45M 5.01M 9.48M 642M 9.66M 64.91M 25.46M 315M 25.18M 24.63M 1.09B
Net income -221M -6.86M -6.02M -5.57M -5.13M -9.7M -657M -9.89M -66.44M -26.06M -323M -25.77M -25.21M -1.11B 466M 14.48M 12.7M 11.76M 10.82M 20.47M 1.39B 20.87M 140M 54.97M 680M 54.36M 53.17M 2.35B
Net Debt 2.06B 63.96M 56.1M 51.96M 47.81M 90.42M 6.12B 92.18M 619M 243M 3.01B 240M 235M 10.38B 1.86B 57.85M 50.74M 47M 43.24M 81.79M 5.54B 83.38M 560M 220M 2.72B 217M 212M 9.39B
Logo General Biologicals Corporation
GENERAL BIOLOGICALS CORP. is a Taiwan-based company principally engaged in the design, development, manufacture, sales and import and export trading of diagnostic kits and auxiliary equipment, as well as the provision of medical technology services. The Company's main products include detection reagents, biological protein new drug, P113, and medical supplies. The Company distributes its products in domestic market and to overseas markets.
Employees
81
Date Price Change Volume
26-07-13 NT$11.25 +7.14% 528,082
26-07-09 NT$10.50 0.00% 249,449
26-07-08 NT$10.50 +3.96% 287,407
26-07-07 NT$10.10 -1.94% 755,855
  1. Stock Market
  2. Stocks
  3. 4117 Stock